Chemed (CHE) Accounts Payables (2009 - 2026)

Chemed has reported Accounts Payables for 18 years, with the latest figure at $65.7 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 37.75% year-over-year to $65.7 million; the trailing twelve-month figure through Mar 2026 stood at $65.7 million (up 37.75% YoY), and the FY2025 full-year result was $64.5 million, up 46.01% from the prior year.
• Accounts Payables for Q1 2026 stood at $65.7 million, up from $64.5 million in the prior quarter.
• The five-year high for Accounts Payables was $77.2 million in Q3 2022, with the low at $40.3 million in Q1 2023.
• Average Accounts Payables over 5 years is $54.4 million, with a median of $50.9 million recorded in 2025.
• Peak annual rise in Accounts Payables reached 52.88% in 2023, while the deepest fall reached 44.5% in 2023.
• Tracing CHE's Accounts Payables over 5 years: stood at $41.9 million in 2022, then jumped by 52.88% to $64.0 million in 2023, then tumbled by 31.06% to $44.1 million in 2024, then jumped by 46.01% to $64.5 million in 2025, then gained by 1.92% to $65.7 million in 2026.
• The last three Accounts Payables figures came in at $65.7 million (Q1 2026), $64.5 million (Q4 2025), and $48.1 million (Q3 2025), per Business Quant data.

Peer Comparison